Tumor Microenvironment in Cancer Hallmarks and Therapeutics

302.9K

views

454

authors

57

articles

Tumor Microenvironment in Cancer Hallmarks and Therapeutics

302.9K

views

454

authors

57

articles

Editorial

12 September 2022

Editorial: Tumor microenvironment in cancer hallmarks and therapeutics

Na Luo

2,912 views

6 citations

Editors

4

Na Luo

School of Medicine, Nankai University

Shengtao Zhou

West China Second University Hospital, Sichuan University

Hongming Miao

Army Medical University

José Alexandre Ferreira

Portuguese Oncology Institute

Impact

Fetching...

About

This Research Topic is part of a series:
-Volume II
-Volume III
Tumor cells reside in an acidic, hypoxic, immunosuppressive, and nutrition-deficient environment, the so-called tumor microenvironment (TME), which induces the reprogramming of metabolism and signaling to support the uncontrolled proliferation of tumor cells. The TME is a complex featuring of blood and lymphatic vessels, stromal cells, immune cells, and extracellular matrix (cytokines, chemokines, collagen, proteoglycans, et al.). The dynamic and reciprocal communication between cancer cells and TME contributes to tumor survival, proliferation, invasion, metastasis, angiogenesis, drug resistance, and immune evasion. For example, tumor cells exploit glycolysis and pentose phosphate pathways to support energy production and macromolecule biosynthesis. Cytotoxic lymphocytes express PD-1 or CTLA-4 that inhibits T cell activity to assist tumor progression. With a comprehensive understanding of the role of TME in tumor development, it provides the possibility of novel therapeutic strategies targeting TME for cancer treatment.
This Research Topic focuses on the contributions of TME to cancer progression and the therapeutic potential of druggable TME targets in cancer treatment, in particular the underlying molecular mechanisms. For example, how does the metabolic reprogramming of TME components assist tumor progression and what are the underlying molecular mechanisms? Are there any potential molecules as druggable targets in TME?
The Research Topic will cover, but is not limited to, the following:
• Metabolic reprogramming in the TME during tumor progression.
• The biology, recruitment, and activation of immune cells or stromal cells in the TME during tumor progression.
• How the cross-talk between TME components and tumor cells contributes to tumor progression.
• Novel strategies for turning immune ‘cold’ tumors into immune ‘hot’ tumors.
• Potential predictive markers and therapeutical targets in the TME.

Download ebook

PDF

EPUB

Share

Editors

Na Luo

School of Medicine, Nankai University

Shengtao Zhou

West China Second University Hospital, Sichuan University

Hongming Miao

Army Medical University

José Alexandre Ferreira

Portuguese Oncology Institute

Impact

302,907 Total views

196,558 Article views

102,116 Article downloads

4,233 Topic views

Published In

Frontiers in Molecular Biosciences

Molecular Diagnostics and Therapeutics

Frontiers in Cell and Developmental Biology

Molecular and Cellular Pathology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic